No data for benefit and real potential risk

The Food and Drug Administration (FDA) warns of the risks, including stroke and death, involved with this experimental procedure.

Currently, there are no well-designed, quality studies to support the safety and effectiveness of venoplasty for treatment of MS symptoms.

May. 06, 2014 See more In-depth